Lisa S. Westerberg
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
AID and TET2 cooperate to demethylate Irf4 for plasma cell fate in germinal center B cells.
Journal: The Journal of experimental medicine
Published: January 16, 2026
Distinct mutations in the autoimmune regulator gene differentially affect transcriptional and functional properties of medullary thymic epithelial cells.
Journal: Human molecular genetics
Published: July 01, 2025
Antigen affinity and site of immunization dictate B cell recall responses.
Journal: Cell reports
Published: May 16, 2024
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
Journal: Science translational medicine
Published: May 15, 2024
SHIP-1 regulates the differentiation and function of Tregs via inhibiting mTORC1 activity.
Journal: Cellular and molecular life sciences : CMLS
Published: September 05, 2023
Exposure of volunteers to microgravity by dry immersion bed over 21 days results in gene expression changes and adaptation of T cells.
Journal: Science advances
Published: August 25, 2023
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 10, 2023
Controlled WASp activity regulates the proliferative response for Treg cell differentiation in the thymus.
Journal: European journal of immunology
Published: February 22, 2023
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation.
Journal: Current research in translational medicine
Published: January 14, 2023
Understanding immunoactinopathies: A decade of research on WAS gene defects.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: December 13, 2022
Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.
Journal: British journal of cancer
Published: July 14, 2022
Last Updated: 09/26/2026